ALS News Today

Guest Voice: I have a new battle plan in my ALS food war

For guest writer Nancy Muirhead, dealing with food and beverages has become unpleasant due to ALS. She's decided to get a PEG ...

Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.

Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially ...

Amyotrophic Lateral Sclerosis (ALS): Early symptoms, root causes, and the science behind motor neuron decline

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological disorder causing motor neuron death, leading to muscle ...
ALS News Today

Researchers find way to make diagnosis of ALS more accurate

Researchers in Germany say combining two blood biomarkers may make the diagnosis of ALS more accurate and help predict ...

Map Shows States With Highest ALS Rates—Study Has ‘Surprising’ Hypothesis

Researcher Melissa Schilling said that she was "surprised to find such a strong geographic pattern" in the U.S. distribution ...
Office of Health Economics

The commercial case for investing in ALS

Amyotrophic lateral sclerosis (ALS) is a rare, rapidly progressive neurodegenerative disease with devastating clinical and ...
The Independent

Eric Dane to guest star as ALS patient on Brilliant Minds amid health struggles

Eric Dane is returning to television to play a character with amyotrophic lateral sclerosis, months after he revealed his own struggle with the neurodegenerative disease. Dane, 52, announced his ...